# Evaluation of the Express Plus Range

> **NCT05051657** · NA · COMPLETED · sponsor: **Vitaflo International, Ltd** · enrollment: 28 (actual)

## Conditions studied

- Phenylketonurias
- PKU
- Homocystinuria
- Maple Syrup Urine Disease
- Hereditary Tyrosinemia
- Glutaric Acidemia I

## Interventions

- **DIETARY_SUPPLEMENT:** PKU express plus

## Key facts

- **NCT ID:** NCT05051657
- **Lead sponsor:** Vitaflo International, Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-14
- **Primary completion:** 2025-09-30
- **Final completion:** 2026-01-21
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05051657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05051657, "Evaluation of the Express Plus Range". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT05051657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*